PLATE 02 · MECHANISM AND THE RECENT RECORD
GHK-Cu research: how a copper tripeptide moves collagen, genes, and neurons
The mechanism, the genome-wide signature, the wound and neuroprotection specimens — each pressed with its dose, species, and route, and its provenance marked where the evidence is early.
How GHK-Cu works
GHK-Cu research begins with a paradox of scale: a tripeptide present at nanomolar plasma concentrations produces measurable, reproducible shifts in tissue behavior. In human fibroblast cultures, GHK-Cu stimulated collagen synthesis from 10^-12 to 10^-11 M, peaking near 10^-9 M, independent of any change in cell number [1]. That dose-response — onset at picomolar, plateau at nanomolar — is the foundational evidence that GHK liberated from collagen drives local repair rather than acting as a structural building block.
The mechanism is copper-dependent and pleiotropic. The Cu(II) ion enables lysyl-oxidase cross-linking of collagen and elastin and a superoxide-dismutase-like antioxidant activity. The peptide scaffold engages TGF-beta/Smad signaling (pro-remodeling in wounds, anti-fibrotic in excess fibrosis), suppresses NF-kB-driven inflammation, and activates the Nrf2/Keap1/HO-1 antioxidant axis [6]. Across these pathways GHK-Cu rebalances matrix metalloproteinases (MMP-2, MMP-9) against their TIMP inhibitors, favoring controlled remodeling over tissue destruction.
Copper Tripeptide-1: The INCI Name for GHK-Cu
Copper Tripeptide-1 is the INCI (International Nomenclature of Cosmetic Ingredients) name for GHK-Cu — the label term used to declare copper-peptide content in skincare. Readers who arrive from a product ingredient list and readers who arrive from a research database are looking at the same molecule: CAS 89030-95-5, molecular formula C14H23CuN6O4+, the glycyl-L-histidyl-L-lysine copper(II) complex. The cosmetic name reflects regulatory framing (a legal cosmetic ingredient), not a different compound; the underlying tripeptide and its copper chelate are identical to the entity described throughout the research literature [3].
Copper Peptide Benefits Reported in the Research Literature
The copper peptide benefits documented across the GHK-Cu literature cluster into four research domains. In skin, GHK-Cu stimulates collagen, dermatan and chondroitin sulfate, and decorin synthesis, with placebo-controlled topical trials reporting improved skin density, firmness, fine lines, and wrinkle depth [3]. In wound repair, it upregulates VEGF, FGF-2, and matrix proteins while suppressing free radicals and inflammation and chemoattracting repair cells [6]. In hair, tissue-remodeling reviews attribute follicle effects to VEGF and FGF-2 angiogenesis [4][6]. At the gene level, GHK shifts expression toward repair, antioxidant, and protein-quality-control programs [2].
These are research findings, catalogued by domain. The strongest controlled human signal is dermatologic and follicular; the systemic and neuroprotective benefits rest largely on in vitro and rodent models. Each domain below is read with its own provenance, and the gaps are marked, not smoothed over.
What genes GHK-Cu modulates
GHK alters expression of roughly 31.2% of human genes at a 50%-or-greater change threshold, with 59% of affected genes upregulated and 41% suppressed, according to Connectivity Map analyses [2]. The strongest single signal is the ubiquitin-proteasome system — the cell's protein-quality-control machinery — with 41 genes up and 1 down. DNA-repair and antioxidant gene sets are also upregulated [2].
The often-quoted figure of "~4,000 genes" is an extrapolation. The verified statistic is the 31.2%-at-50%-change table, which reports on the order of 2,100 genes at that threshold; broader-threshold counts inflate the number [2]. The gene data derives largely from database analyses that still need protein-level in vivo validation — a meaningful caveat catalogued here in plain sight.
The neuroprotection specimens: the freshest plates
The most recently pressed specimens in this folio are neuroprotective, and they carry preprint provenance. Intranasal GHK peptide (15 mg/kg daily, 8 weeks) in 20-month-old C57BL/6 mice improved spatial memory and learning versus saline controls and reduced the axonal-damage marker NFL-1 in both sexes [8]. In 5xFAD transgenic Alzheimer-model mice, intranasal GHK (15 mg/kg, three times weekly, 12 weeks) improved maze performance, reduced amyloid plaque burden in frontal cortex and hippocampus, and decreased the neuroinflammation marker MCP-1 [13].
The mechanism reported in 2024 is metal sequestration rather than antioxidant signaling: GHK without copper prevented copper- and zinc-induced protein aggregation and cell death in CNS neurons, microglia, and astrocytes in vitro, completely preventing copper-induced DLAT aggregation (a cuproptosis marker) [10]. A biotinylated GHK and its copper complex showed antioxidant and antiglycant protection against amyloid-beta/acrolein adducts in cell-free assays at 0-30 uM [11]. Rodent behavioral work adds anxiolytic [14] and anti-aggression [15] effects of free GHK. Two of the cognitive studies are bioRxiv preprints; that status is catalogued here, not hidden.
What Genes Does GHK-Cu Affect?
Connectivity Map analyses report GHK alters about 31.2% of human genes at a 50%-or-greater change threshold (59% up, 41% down), strongly upregulating the ubiquitin-proteasome system (41 genes up, 1 down) and DNA-repair and antioxidant sets [2]. The frequently quoted "~4,000 genes" figure is an extrapolation; the threshold table reports on the order of 2,100 genes [2].
Can GHK-Cu Help with Wound Healing?
Across rodent and biomaterial models GHK-Cu accelerates wound closure by upregulating VEGF, FGF-2, and matrix proteins, suppressing free radicals and inflammation, and chemoattracting repair cells [6]. A biotinylated-GHK collagen matrix accelerated dermal wound healing in rats [12]. The human wound-healing evidence is still early, and one topical wound trial is registered but not completed.
Does GHK-Cu Affect Inflammation?
Tissue-remodeling reviews report GHK-Cu suppresses TGF-beta-1, TNF-alpha, and free-radical activity while chemoattracting repair cells, consistent with NF-kB suppression and Nrf2 antioxidant activation [6]. The anti-inflammatory data is drawn from in vitro and rodent models, not controlled human trials.
Is GHK-Cu Really Anti-Aging?
Plasma GHK declines from about 200 ng/mL at age 20 to about 80 ng/mL by age 60, and topical GHK-Cu increased procollagen in 70% of treated subjects versus 40% for retinoic acid in reviewed trials [3][9]. Gene-expression analyses report shifts toward repair and antioxidant programs [2], though much of this rests on in vitro and database work.
GHK vs GHK-Cu: Why the Copper Matters
GHK is the free tripeptide (MW 340.38); GHK-Cu is its copper(II) chelate (MW 402.92). Copper coordination is required for most documented tissue-repair activities — the free peptide does not reproduce MMP-2 stimulation in fibroblasts [1]. Many neuroprotection studies use free GHK, so the form used in a given study matters when reading a claim.
What Is the Neuroprotective Research on GHK-Cu?
GHK (the free tripeptide) prevented copper- and zinc-induced protein aggregation and CNS cell death in vitro by sequestering extracellular copper [10]. Intranasal GHK improved spatial memory in aged and 5xFAD Alzheimer-model mice and reduced amyloid and neuroinflammation markers [8][13]. Gene analyses report upregulation of neuron-associated genes [2]. All of this evidence is preclinical, and the mouse studies are preprints.
Can GHK-Cu Reach the Brain?
No validated human blood-brain-barrier penetration data exists. The rodent neuroprotection studies delivered GHK intranasally at 15 mg/kg [8][13], a route that can bypass the blood-brain barrier for nose-to-brain transport; in vitro neuronal work added the peptide directly to cell cultures [10]. Systemic central exposure in humans has not been established.